📰 Current Management News
Page 2 - Current Management News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Current Management. Real-time updates on events, politics, business and more.
June 1, 2023
/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the presentation of results from two clinical...
May 8, 2023
/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the presentation of results from two clinical...
May 5, 2023
/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, is pleased to announce it has received an award from the...
May 1, 2023
/PRNewswire/ -- DelveInsights Glioma Market Insights report includes a comprehensive understanding of current treatment practices, glioma emerging drugs,...
April 10, 2023
/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that two scientific abstracts on the clinical...
January 22, 2023
/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the presentation of results from a...
November 20, 2022
This article is part two of a two-part series. Part one ran last week and described the symptoms, ...
November 1, 2022
/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that three scientific abstracts on clinical...
October 24, 2022
/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, today announced that five scientific abstracts on the clinical...
September 15, 2022
/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA)...